1. Home
  2. AVTX vs SCWO Comparison

AVTX vs SCWO Comparison

Compare AVTX & SCWO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AVTX
  • SCWO
  • Stock Information
  • Founded
  • AVTX 2011
  • SCWO 2021
  • Country
  • AVTX United States
  • SCWO United States
  • Employees
  • AVTX N/A
  • SCWO N/A
  • Industry
  • AVTX Biotechnology: Pharmaceutical Preparations
  • SCWO Environmental Services
  • Sector
  • AVTX Health Care
  • SCWO Utilities
  • Exchange
  • AVTX Nasdaq
  • SCWO Nasdaq
  • Market Cap
  • AVTX 57.4M
  • SCWO 56.4M
  • IPO Year
  • AVTX 2015
  • SCWO N/A
  • Fundamental
  • Price
  • AVTX $4.80
  • SCWO $0.19
  • Analyst Decision
  • AVTX Strong Buy
  • SCWO
  • Analyst Count
  • AVTX 7
  • SCWO 0
  • Target Price
  • AVTX $31.00
  • SCWO N/A
  • AVG Volume (30 Days)
  • AVTX 81.3K
  • SCWO 1.4M
  • Earning Date
  • AVTX 08-11-2025
  • SCWO 08-13-2025
  • Dividend Yield
  • AVTX N/A
  • SCWO N/A
  • EPS Growth
  • AVTX N/A
  • SCWO N/A
  • EPS
  • AVTX N/A
  • SCWO N/A
  • Revenue
  • AVTX $441,000.00
  • SCWO $673,267.00
  • Revenue This Year
  • AVTX N/A
  • SCWO $5,945.19
  • Revenue Next Year
  • AVTX N/A
  • SCWO $106.82
  • P/E Ratio
  • AVTX N/A
  • SCWO N/A
  • Revenue Growth
  • AVTX N/A
  • SCWO 161.19
  • 52 Week Low
  • AVTX $3.39
  • SCWO $0.16
  • 52 Week High
  • AVTX $16.00
  • SCWO $1.99
  • Technical
  • Relative Strength Index (RSI)
  • AVTX 51.53
  • SCWO 34.46
  • Support Level
  • AVTX $4.61
  • SCWO $0.18
  • Resistance Level
  • AVTX $5.02
  • SCWO $0.44
  • Average True Range (ATR)
  • AVTX 0.26
  • SCWO 0.04
  • MACD
  • AVTX -0.02
  • SCWO -0.01
  • Stochastic Oscillator
  • AVTX 54.55
  • SCWO 11.73

About AVTX Avalo Therapeutics Inc.

Avalo Therapeutics Inc is a clinical-stage biotechnology company focused on the treatment of immune dysregulation. The company's asset is AVTX-009, an anti-IL-1B monoclonal antibody ("mAb"), targeting inflammatory diseases. Avalo's pipeline also includes quisovalimab (anti-LIGHT mAb) and AVTX-008 (BTLA agonist fusion protein).

About SCWO 374Water Inc.

374Water Inc offers a technology that transforms wet wastes such as sewage sludge, biosolids, food waste, hazardous and non-hazardous waste, and forever chemicals (e.g., PFAS) into recoverable resources by focusing on waste as a valuable resource for water, energy, and minerals. The company's business activities include manufacturing processes and waste recycling and treatment processes, which currently involve the use, treatment, storage, transfer, handling and/or disposal of hazardous materials, chemicals and wastes.

Share on Social Networks: